Diffuse Lung Disease & Interstitial Lung Disease Archives - Page 3 of 3 - PulmCCM
Advertisement


Diffuse Lung Disease & Interstitial Lung Disease Articles

Feb 182011
 

McCormack et al randomized 89 women with lymphangioleiomyomatosis to receive 2 mg rapamycin or placebo daily for 12 months, followed by 12 months of drug-free observation. Women receiving sirolimus had stable lung function on spirometry, fewer symptoms, fewer “respiratory events,” and better quality of life during the treatment period. This was tempered by GI, dermatologic, [... read more]